BBGI vs REGN · rev $240.3M vs P/E 14, rev $14.34B
Beasley Broadcast Group Inc (BBGI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Beasley Broadcast Group Inc (BBGI) is a broadcasting company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BBGI revenue for 2024-12-31 was $240.3M. Net income was -$5.9M. Revenue was down 2.8% from 2023-12-31 to 2024-12-31. BBGI currently screens at market cap $36.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BBGI currently screens at market cap $36.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BBGI and REGN stock pages for the full models.
Not investment advice.